Home

Case Study

Minimising The Risk And Reinforcing Patient Safety For Novartis Products

Minimising The Risk And Reinforcing Patient Safety For Novartis Products

GS1
Pages 2 Pages

29 2013/2014 GS1 Healthcare Reference Book Minimising the Risk and Reinforcing Patient Safety for Novartis Products ABSTRACT In 2010, Novartis Pharma in Portugal developed and implemented a traceability programme using GS1 2D DataMatrix. This programme allows to track the product, from the warehouse to the patient, including all the moves in the hospital from the pharmacy to the operating theatre. It also enables online status checks in the c

Join for free to read

Related Solution Sets

Pharmaceutical & Life Science Industries
Healthcare Industry

You Might Also Like


Addressing Modern Challenges to Infusion Pump Availability, Performance and Patient Safety
White Paper Addressing Modern Challenges to Infusion Pump Availability,…
Braun

Novartis and Model N: Partners in Revenue Management
Case Study Novartis and Model N: Partners in Revenue Management
Model N

Novartis Corporate HQ
Case Study Novartis Corporate HQ
Creative Materials Corp

Developing a Safety Culture in the Healthcare Workplace
White Paper Developing a Safety Culture in the Healthcare Workplace
UL Workplace

More from GS1


Better Immunization Management for Patient Safety
Case Study Better Immunization Management for Patient Safety
GS1

Better Immunisation Management For Patient Safety
Case Study Better Immunisation Management For Patient Safety
GS1

TFDA, CCH And GS1 Taiwan Advancing GS1 Barcodes To Improve Patient Safety
Case Study TFDA, CCH And GS1 Taiwan Advancing GS1 Barcodes To Improve…
GS1

Georgia-Pacific Proves the Value of Where and Who; Adding GS1 Global Location Numbers to its data set adds efficiency
Case Study Georgia-Pacific Proves the Value of Where and Who; Adding GS1…
GS1
© 2025 Contentree.  All Rights Reserved   |   Privacy and Cookies   |   Legal   |   Do not sell my info